Factor V Leiden Thrombophilia Latest Advances

Activated Protein C Sensitivity Assessed with Thrombin Generation Assay in Antiphospholipid Syndrome Women: Results from Two French Cohorts.

Journal: Thrombosis and haemostasis

Published: January 28, 2026

Diagnosing thrombophilia: the case for genetic or functional testing?

Journal: Expert review of molecular diagnostics

Published: November 10, 2025

Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives.

Journal: Research and practice in thrombosis and haemostasis

Published: October 23, 2025

Rationalisation of a thrombophilia panel using laboratory medicine Delphi-like consensus evaluation and secondary artificial intelligence-based simulation assessment.

Journal: Diagnosis (Berlin, Germany)

Published: September 29, 2025

Screening of Factor V Leiden mutation and activated protein C resistance in Sudanese children with sickle cell disease and stroke: A descriptive cross-sectional study.

Journal: Medicine

Published: July 09, 2025

Assessment of thrombophilia in patients with lupus anticoagulant.

Journal: Thrombosis research

Published: June 13, 2025

Commentary: The ETP-based APC resistance assay remains the gold standard for evaluating the APC resistance phenotype in users of combined oral contraceptives.

Journal: Frontiers in cardiovascular medicine

Published: April 14, 2025

Trans-kingdom conservation of mechanism between bacterial actifensin and eukaryotic defensins.

Journal: npj antimicrobials and resistance

Published: March 31, 2025

Endothelium Modulates the Prothrombotic Phenotype of Factor V Leiden: Evidence From an Ex Vivo Model.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: January 23, 2025

Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis.

Journal: Thrombosis research

Published: October 02, 2024

Activated Protein C Resistance Testing: An Update From Australasia/Asia-Pacific.

Journal: International journal of laboratory hematology

Published: October 02, 2024

Understanding the difference between type I and type II antiprothrombin antibodies and their effect on activated protein C resistance.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 20, 2024

Factor V Leiden Thrombophilia Latest Advances

Find the Latest Research About Factor V Leiden Thrombophilia

Activated Protein C Sensitivity Assessed with Thrombin Generation Assay in Antiphospholipid Syndrome Women: Results from Two French Cohorts.

Activated Protein C Sensitivity Assessed with Thrombin Generation Assay in Antiphospholipid Syndrome Women: Results from Two French Cohorts.

Diagnosing thrombophilia: the case for genetic or functional testing?

Diagnosing thrombophilia: the case for genetic or functional testing?

Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives.

Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives.

Rationalisation of a thrombophilia panel using laboratory medicine Delphi-like consensus evaluation and secondary artificial intelligence-based simulation assessment.

Rationalisation of a thrombophilia panel using laboratory medicine Delphi-like consensus evaluation and secondary artificial intelligence-based simulation assessment.

Screening of Factor V Leiden mutation and activated protein C resistance in Sudanese children with sickle cell disease and stroke: A descriptive cross-sectional study.

Screening of Factor V Leiden mutation and activated protein C resistance in Sudanese children with sickle cell disease and stroke: A descriptive cross-sectional study.

Assessment of thrombophilia in patients with lupus anticoagulant.

Assessment of thrombophilia in patients with lupus anticoagulant.

Commentary: The ETP-based APC resistance assay remains the gold standard for evaluating the APC resistance phenotype in users of combined oral contraceptives.

Commentary: The ETP-based APC resistance assay remains the gold standard for evaluating the APC resistance phenotype in users of combined oral contraceptives.

Trans-kingdom conservation of mechanism between bacterial actifensin and eukaryotic defensins.

Trans-kingdom conservation of mechanism between bacterial actifensin and eukaryotic defensins.

Endothelium Modulates the Prothrombotic Phenotype of Factor V Leiden: Evidence From an Ex Vivo Model.

Endothelium Modulates the Prothrombotic Phenotype of Factor V Leiden: Evidence From an Ex Vivo Model.

Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis.

Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis.

Activated Protein C Resistance Testing: An Update From Australasia/Asia-Pacific.

Activated Protein C Resistance Testing: An Update From Australasia/Asia-Pacific.

Understanding the difference between type I and type II antiprothrombin antibodies and their effect on activated protein C resistance.

Understanding the difference between type I and type II antiprothrombin antibodies and their effect on activated protein C resistance.